Intensive Induction Chemotherapy With CBOP/BEP in Patients With Poor Prognosis Germ Cell Tumors
J. Christian(Royal Marsden Hospital), A. Horwich(Institute of Cancer Research), Nina Aass(Royal Marsden Hospital), Malcolm D. Mason(Royal Marsden Hospital), E.J. Nicholl(Royal Marsden Hospital), Robert Huddart(Institute of Cancer Research), Sophie D. Fosså(Norwegian Cancer Society), D.P. Dearnaley(Royal Marsden NHS Foundation Trust), A. Norman(Royal Marsden NHS Foundation Trust)
Cited by 66
Related Papers
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
|The Lancet|2008|873
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830
Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924
|Journal of Clinical Oncology|2001|628